Octagon Capital Advisors LP - ITEOS THERAPEUTICS INC ownership

ITEOS THERAPEUTICS INC's ticker is ITOS and the CUSIP is 46565G104. A total of 153 filers reported holding ITEOS THERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is 1.92 and the average weighting 0.2%.

Quarter-by-quarter ownership
Octagon Capital Advisors LP ownership history of ITEOS THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$1,116,900
-85.8%
102,000
-82.9%
0.17%
-84.3%
Q2 2023$7,891,040
-2.7%
596,0000.0%1.10%
-5.9%
Q1 2023$8,111,560
-6.7%
596,000
+33.9%
1.17%
-13.7%
Q4 2022$8,690,850
-40.1%
445,000
-1.3%
1.35%
-56.9%
Q1 2022$14,506,000
-30.9%
450,7760.0%3.14%
-23.2%
Q4 2021$20,988,000450,7764.08%
Other shareholders
ITEOS THERAPEUTICS INC shareholders Q1 2023
NameSharesValueWeighting ↓
MPM ASSET MANAGEMENT LLC 2,738,785$37,274,86415.53%
MPM BioImpact LLC 1,745,943$23,762,2846.17%
Saturn V Capital Management LP 480,653$6,541,6874.89%
Boxer Capital, LLC 2,154,058$29,3171.44%
RA Capital Management 4,417,259$60,118,8951.36%
Octagon Capital Advisors LP 596,000$8,111,5601.17%
BVF INC/IL 1,810,835$24,645,4640.90%
AlphaCentric Advisors LLC 63,000$857,4300.59%
Integral Health Asset Management, LLC 180,000$2,449,8000.49%
683 Capital Management, LLC 480,000$6,532,8000.49%
View complete list of ITEOS THERAPEUTICS INC shareholders